BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22018556)

  • 1. Improving our understanding of the prevention of human papillomavirus.
    Irwin CE; Berg TD
    J Adolesc Health; 2011 Nov; 49(5):449. PubMed ID: 22018556
    [No Abstract]   [Full Text] [Related]  

  • 2. HPV vaccination in Southern Africa: A jab of hope in the fight against cervical cancer.
    Michelow P; Firnhaber C
    Cancer Cytopathol; 2016 Oct; 124(10):695-698. PubMed ID: 27182785
    [No Abstract]   [Full Text] [Related]  

  • 3. The need for forward-looking decision analyses to guide cervical cancer prevention.
    Schiffman M
    Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):219-20. PubMed ID: 21300615
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial: Recent Advances in Molecular Detection of Human Papillomavirus and Cervical Cancer Screening.
    Poljak M; Ginocchio CC
    J Clin Virol; 2016 Mar; 76 Suppl 1():S1-S2. PubMed ID: 26597652
    [No Abstract]   [Full Text] [Related]  

  • 5. Human papillomavirus vaccines: understanding the benefit-risk.
    Neels P; van Damme P; van Ranst M; Dogné JM
    Ann Med; 2013 May; 45(3):203-5. PubMed ID: 22758373
    [No Abstract]   [Full Text] [Related]  

  • 6. HPV, vaccines, and cervical cancer in a low- and middle-income country.
    Petersen LM; Fenton JM; Kennedy LS; LaRochelle EPM; Bejarano S; Tsongalis GJ
    Curr Probl Cancer; 2020 Dec; 44(6):100605. PubMed ID: 32507365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical cancer and prevention by vaccination: results from recent trials.
    Tjalma WA
    Ann Oncol; 2006 Sep; 17 Suppl 10():x217-23. PubMed ID: 17018727
    [No Abstract]   [Full Text] [Related]  

  • 8. HPV9 Vaccine for the Prevention of Human Papillomavirus-Related Cancers.
    Fontenot HB; Fantasia HC
    Nurs Womens Health; 2015; 19(4):365-70. PubMed ID: 26264802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Who should be vaccinated against human papillomavirus?
    Tjalma WA; van Damme P
    Int J Gynecol Cancer; 2006; 16(4):1498-9. PubMed ID: 16884357
    [No Abstract]   [Full Text] [Related]  

  • 10. HPV-vaccine and screening programs: the new era of global prevention.
    Mariani L
    J Prev Med Hyg; 2009 Jun; 50(2):90-5. PubMed ID: 20099438
    [No Abstract]   [Full Text] [Related]  

  • 11. Human papillomavirus.
    Brody H
    Nature; 2012 Aug; 488(7413):S1. PubMed ID: 22932432
    [No Abstract]   [Full Text] [Related]  

  • 12. Current clinical trials of HPV vaccines.
    Trimble EL; Schoenfeldt M
    Oncology (Williston Park); 2004 Jun; 18(7):859-60, 862. PubMed ID: 15255170
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prophylactic vaccination against HP viruses for the prevention of cervical cancer : Implementation of gender neutral, prophylactic vaccination in Germany as an effective instrument for prevention].
    Huck N
    Urologe A; 2018 Jul; 57(7):850-851. PubMed ID: 29946934
    [No Abstract]   [Full Text] [Related]  

  • 14. [Papillomavirus, could we speak about cancer and prevention?].
    Pernot S; Pavie J; Péré H; Menard M; Hurel S; Cochand-Priollet B; Bats AS; Badoual C
    Bull Cancer; 2018 Feb; 105(2):137-139. PubMed ID: 29373106
    [No Abstract]   [Full Text] [Related]  

  • 15. Investigational 9-valent HPV vaccine could prevent almost 90% of cervical cancers.
    Hum Vaccin Immunother; 2014; 10(11):3105-6. PubMed ID: 25789368
    [No Abstract]   [Full Text] [Related]  

  • 16. Variation in genital human papillomavirus infection prevalence and vaccination coverage among men and women in the USA.
    Han JJ; Tarney CM; Song J
    Future Oncol; 2017 Jun; 13(13):1129-1132. PubMed ID: 28589730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additional Protection from 9-Valent HPV Vaccine if Administered Before HPV Exposure.
    Joura E; Clark L; Luxembourg A
    Am Fam Physician; 2016 Feb; 93(4):254-6. PubMed ID: 26926809
    [No Abstract]   [Full Text] [Related]  

  • 18. Reduction in subsequent HPV related disease was unrelated to vaccination.
    Fiala C
    BMJ; 2012 May; 344():e3195; author reply e3198. PubMed ID: 22570208
    [No Abstract]   [Full Text] [Related]  

  • 19. Anticipating full benefits from the new papillomavirus vaccines.
    Griffiths PD
    Rev Med Virol; 2007; 17(1):1-3. PubMed ID: 17173349
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of quadrivalent HPV vaccination on HPV related disease in women treated for cervical or vulvar/vaginal disease.
    Kim JJ
    BMJ; 2012 Mar; 344():e1544. PubMed ID: 22454090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.